| |
| |
|
| Insider
Information: |
Hamel Lawrence G |
| Relationship: |
Chief Development Offi... |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
127,769 |
|
|
Indirect Shares
|
29,795 |
|
|
| Direct
Value |
$131,602 |
|
|
|
Indirect Value
|
$30,689 |
|
|
| Total
Shares |
157,564 |
|
|
| Total
Value |
$162,291 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acelrx Pharmaceuticals Inc |
ACRX |
Chief Development Offi... |
2020-02-11 |
127,769 |
2020-02-11 |
29,795 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,899 |
16,899 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2011-09-02 |
4 |
D |
$3.10 |
$4,771 |
D/D |
(1,539) |
15,360 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2012-03-02 |
4 |
D |
$2.91 |
$4,996 |
D/D |
(1,717) |
13,643 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2013-03-02 |
4 |
D |
$4.96 |
$7,683 |
D/D |
(1,549) |
26,578 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2013-09-17 |
4 |
D |
$10.71 |
$10,710 |
D/D |
(1,000) |
30,708 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2013-09-17 |
4 |
A |
$1.20 |
$5,324 |
D/D |
4,437 |
31,708 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2013-10-17 |
4 |
A |
$1.20 |
$4,224 |
D/D |
3,520 |
34,228 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2013-10-17 |
4 |
D |
$8.54 |
$8,540 |
D/D |
(1,000) |
33,228 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2013-11-18 |
4 |
A |
$1.20 |
$4,120 |
D/D |
3,433 |
36,661 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2013-11-18 |
4 |
D |
$8.30 |
$8,300 |
D/D |
(1,000) |
35,661 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2013-12-17 |
4 |
D |
$9.80 |
$9,800 |
D/D |
(1,000) |
38,719 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2013-12-17 |
4 |
A |
$1.20 |
$4,870 |
D/D |
4,058 |
39,719 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-01-17 |
4 |
A |
$1.20 |
$6,340 |
D/D |
5,283 |
41,944 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-01-17 |
4 |
D |
$12.74 |
$12,740 |
D/D |
(1,000) |
40,944 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-01-17 |
4/A |
A |
$1.20 |
$6,340 |
D/D |
5,283 |
44,002 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-01-17 |
4/A |
D |
$12.74 |
$12,740 |
D/D |
(1,000) |
43,002 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-02-18 |
4 |
A |
$1.20 |
$5,854 |
D/D |
4,878 |
47,880 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-02-18 |
4 |
D |
$11.77 |
$11,770 |
D/D |
(1,000) |
46,880 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-03-02 |
4 |
D |
$11.43 |
$17,934 |
D/D |
(1,569) |
47,834 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-03-17 |
4 |
D |
$12.58 |
$12,580 |
D/D |
(1,000) |
52,050 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-03-17 |
4 |
A |
$1.20 |
$6,259 |
D/D |
5,216 |
53,050 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-04-17 |
4 |
A |
$1.20 |
$5,195 |
D/D |
4,329 |
56,379 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-04-17 |
4 |
D |
$10.45 |
$10,450 |
D/D |
(1,000) |
55,379 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-05-19 |
4 |
A |
$1.20 |
$4,390 |
D/D |
3,658 |
59,037 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
Chief Development Officer |
• – – |
2014-05-19 |
4 |
D |
$8.84 |
$8,840 |
D/D |
(1,000) |
58,037 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
